Patents by Inventor John S. Walsh

John S. Walsh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030001965
    Abstract: A system and method of coordinating a visual display with audio advertisements broadcast over a communications network such as the Internet is provided. A run-time procedure in which the visual display is retrieved and concurrently displayed at about the time the audio advertisement is broadcast is described. In addition, a set-up procedure, in which scheduled broadcast times for the audio advertisements are captured and provided for use in scheduling the broadcasts of the corresponding visual displays, is also described. The system and method can be beneficially employed in other environments, such as the case in which a first audio, visual, or audiovisual segment or stream is coordinated with a predetermined second audio, visual, or audiovisual segment or stream, and a selected one of the first and second segments or streams includes or comprises advertising material.
    Type: Application
    Filed: April 1, 2002
    Publication date: January 2, 2003
    Applicant: Radiowave.Com Inc.
    Inventors: XiWei Cao, Edwin C. Price, Mike H. Kim, John S. Walsh
  • Patent number: 4678799
    Abstract: A group of 4-substituted-5-nitroimidazoles is described, having effective antiprotozoal activity with much less mutagenicity than is shown by known 5-nitroimidazoles.
    Type: Grant
    Filed: December 24, 1984
    Date of Patent: July 7, 1987
    Assignee: Merck & Co., Inc.
    Inventors: Gerald T. Miwa, John S. Walsh
  • Patent number: 4675337
    Abstract: The invention relates to novel 1,2-disubstituted-4-nitroimidazole compounds that are useful as potent antiprotozoal agents and simultaneously possess non-mutagenicity as compared to known 4- or 5-nitroimidazole compounds. Also, compositions and methods for antiprotozoal uses of said novel 1,2-disubstituted-4-nitroimidazole compounds are disclosed herein.
    Type: Grant
    Filed: February 28, 1986
    Date of Patent: June 23, 1987
    Assignee: Merck & Co., Inc.
    Inventors: Gerald T. Miwa, Wen-Jen R. Wang, John S. Walsh
  • Patent number: 4333925
    Abstract: There are disclosed certain new derivatives of C-076 compounds which have been isolated from the livers of animals that had been administered ivermectin and the in vitro incubation of such compounds with animal liver preparations. The compounds retain the basic ivermectin structure, however, 24-methyl group has been oxidized to a hydroxy methyl group and, in some of the new compounds the disaccharide substituent of the starting materials has been cleaved to a monosaccharide moiety. The new compounds have been found to retain the biological activity of the parent C-076 compounds. The compounds are thus potent antiparasitic agents and compositions and methods for such uses are also disclosed.
    Type: Grant
    Filed: May 11, 1981
    Date of Patent: June 8, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Rudolf P. Buhs, Theodore A. Jacob, Gerald Miwa, Elena Sestokas, Rae Taub, John S. Walsh